DIA Global 2023
Spencer Group’s CEO, Julian Minett, Shares Insights from DIA 2023 Event: AI, Diversity, and Patient Centricity at the Forefront
More
Outsourcing Clinical Trials and Clinical Trials Supply Event in Copenhagen
Julian Minett, CEO of Spencer Group is looking forward to attending this year’s Outsourcing Clinical Trials and Clinical Trials Supply Event in…
Spencer Group attend the Scrip Awards
Spencer Group were delighted to attend the 17th edition of the Scrip Awards on the 2nd December, hosted live in London. The…
Decentralised trials, is this the new normal for clinical trials?
We are excited to be speaking to Steve Geffon, a highly experienced commercial lead in the eclinical and services market. Steve is…
What are the possible implications of Covid-19 on the biopharmaceutical and the wider pharmaceutical markets?
Steve Kent is currently Non-Executive Chairman at Phlexglobal, 4ways and Pharmaspectra, as well as Non-Executive Director at Imagen Therapeutics. During Steve’s time…
What are the possible implications of Covid-19 on the pharmaceutical technology sector?
Steve Powell is a renowned, international expert with a career spanning over 30 years within pharmaceutical technology. He has worked for organisations such…
Neil Rotherham: What is the impact of Covid-19 on the pharmaceutical technology market?
Neil Rotherham is a serial entrepreneur with over 25 year’s experience in the pharmaceutical and medical technology markets with proven experience of…
What implications will coronavirus have on higher education?
Geoff Webster is Managing Director of CEG Digital, a division of Cambridge Education Group specialising in partnering with high quality UK, EU,…
What implications will coronavirus have on Real World Evidence/data and the wider eclinical market?
Tim Davis, CEO of Raremark, a real world evidence/data organisation in the rare diseases space, discusses the possible implications coronavirus will have…
Building a successful eclinical businesses
Experienced entrepreneur Tim Davis, one of the founders and ex-CEO of Exco in Touch before its strategic sale to ERT, discusses his…